Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Codiak

Codiak?uq=kzBhZRuG
2015 FOUNDED
PRIVATE STATUS
Series C LATEST DEAL TYPE
$76.5M LATEST DEAL AMOUNT
10 INVESTORS
Description

Developer of tiny membrane sacs called exosomes designed for treating cancer and other diseases. The company's exosome therapeutics carry information about red blood cells and mediate inter-cellular communication in both therapeutics and diagnostics, build and expand upon the natural tropism of exosomes for delivery of payloads to specific cell and tissue types, enabling users to solve the challenges of delivering macromolecules across biological membranes.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Diagnostic Equipment
Primary Office
  • 500 Technology Square
  • 9th Floor
  • Cambridge, MA 02139
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Codiak’s full profile, request a free trial.

Codiak Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 29-Nov-2017 $76.5M 00000 00000 Completed Pre-Clinical Trials
2. Early Stage VC (Series B) 26-Jan-2016 0000 0000 00000 Completed Product Development
1. Early Stage VC (Series A) 25-Nov-2015 $31M $31M 0000 Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

Codiak Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 00,000,000 00.000000 00.0 00.00 00.00 00 00.00 00.00
Series B 00,000,000 00.000000 00.00 00 00 00 00 00.000
Series A 33,200,000 $0.000100 $0.08 $1 $1 1x $1 31.4%
To view this company’s complete Cap Table, request access »

Codiak Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Casdin Capital Venture Capital Minority 000 0000 000000 0
EcoR1 Capital Hedge Fund Minority 000 0000 000000 0
Qatar Investment Authority Sovereign Wealth Fund Minority 000 0000 000000 0
Sirona Biochem PE-Backed Company Minority 000 0000 000000 0
Tavistock Group PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Codiak Executive Team (10)

Name Title Board
Seat
Contact
Info
Douglas Williams Ph.D President, Chief Executive Officer & Board Member
Linda Bain Chief Financial Officer
Richard Brudnick Chief Business Officer & Head, Strategy
Eric Lander Ph.D Scientific Co-Founder & Board Member
Raghu Kalluri Ph.D Scientific Co-Founder & Board Member

1 Former Executive

You’re viewing 5 of 10 executives. Get the full list »

Codiak Board Members (7)

Name Representing Role Since Contact
Info
Avak Kahvejian Ph.D Flagship Pioneering Board Member 000 0000
Briggs Morrison MD Self Board Member 000 0000
Charles Cooney Ph.D Self Board Member 000 0000
Eric Lander Ph.D Codiak Scientific Co-Founder & Board Member 000 0000
Noubar Afeyan Ph.D Flagship Pioneering Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »